Abiopharma

🔍 Empery Asset Management, LP (Executive)

Company: Empery Digital Inc. (EMPD)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 500,000 shares of Common Stock at $3.5862 per share (Direct)
  Date: 2026-09-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 4,930,345.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F1

Footnotes:

• F1: The shares of common stock were purchased by Empery Asset Master, Ltd. and Empery Tax Efficient, LP (collectively the "EAM Funds"). Empery Asset Management, LP ("EAM") serves as the investment manager of each of the EAM Funds. Ryan M. Lane is the Managing Member of Empery AM GP, LLC, the general partner of EAM. The Reporting Persons may be deemed to beneficially own the securities held by the EAM Funds. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interest therein, if any.
• F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.19 to $3.77 per share, inclusive. The Reporting Persons undertake to provide to Empery Digital Inc., any security holder of Empery Digital Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
• F3: The securities reported in Column 5 comprise: (i) 100,000 shares of common stock held directly by Mr. Lane, and (ii) 4,830,345 shares of common stock held of record by funds affiliated with EAM, including the EAM Funds (such funds, collectively, the "Empery Funds"). The Reporting Persons may be deemed to beneficially own the securities held by the Empery Funds. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interest therein, if any.